Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”

Detalles Bibliográficos
Autores principales: Picardi, Marco, Giordano, Claudia, Della Pepa, Roberta, Cerchione, Claudio, Pugliese, Novella, Leone, Aldo, Vitiello, Selenia, Pane, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248065/
https://www.ncbi.nlm.nih.gov/pubmed/33251661
http://dx.doi.org/10.1111/ejh.13558
_version_ 1783716646698876928
author Picardi, Marco
Giordano, Claudia
Della Pepa, Roberta
Cerchione, Claudio
Pugliese, Novella
Leone, Aldo
Vitiello, Selenia
Pane, Fabrizio
author_facet Picardi, Marco
Giordano, Claudia
Della Pepa, Roberta
Cerchione, Claudio
Pugliese, Novella
Leone, Aldo
Vitiello, Selenia
Pane, Fabrizio
author_sort Picardi, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-8248065
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82480652021-07-02 Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671” Picardi, Marco Giordano, Claudia Della Pepa, Roberta Cerchione, Claudio Pugliese, Novella Leone, Aldo Vitiello, Selenia Pane, Fabrizio Eur J Haematol Letter to the Editors John Wiley and Sons Inc. 2021-03-02 2021-05 /pmc/articles/PMC8248065/ /pubmed/33251661 http://dx.doi.org/10.1111/ejh.13558 Text en © 2020 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letter to the Editors
Picardi, Marco
Giordano, Claudia
Della Pepa, Roberta
Cerchione, Claudio
Pugliese, Novella
Leone, Aldo
Vitiello, Selenia
Pane, Fabrizio
Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title_full Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title_fullStr Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title_full_unstemmed Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title_short Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
title_sort correspondence in reference to previously published manuscript: “faouzi djebbari et al. efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. eur j haematol. 2020; 105: 667‐671”
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248065/
https://www.ncbi.nlm.nih.gov/pubmed/33251661
http://dx.doi.org/10.1111/ejh.13558
work_keys_str_mv AT picardimarco correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT giordanoclaudia correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT dellapeparoberta correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT cerchioneclaudio correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT pugliesenovella correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT leonealdo correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT vitielloselenia correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671
AT panefabrizio correspondenceinreferencetopreviouslypublishedmanuscriptfaouzidjebbarietalefficacyandinfectionmorbidityoffrontlineimmunochemotherapyinfollicularlymphomaeurjhaematol2020105667671

Ejemplares similares